1. Zhang S, Taylor AK, Huang X, Luo B, Spector EB, Fang P, Richards CS (2018) Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 20(12):1489–1498. https://doi.org/10.1038/s41436-018-0322-z
2. Zöller B, Svensson PJ, Dahlbäck B, Lind-Hallden C, Hallden C, Elf J (2020) Genetic risk factors for venous thromboembolism. Expert Rev Hematol 13(9):971–981. https://doi.org/10.1080/17474086.2020.1804354
3. Foy P, Moll S (2009) Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med 11(2):114–128. https://doi.org/10.1007/s11936-009-0012-x
4. Kujovich JL (1993) Prothrombin thrombophilia. In: Adam MP, Mirzaa GM, Pagon RA et al (eds) GeneReviews(®). University of Washington, Seattle copyright © 1993–2022, University of Washington. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved, Seattle
5. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 341(11):801–806